Our Board members dedicate their time and energy to working with Ovarian Cancer Australia on an honourary basis, bringing a wealth of experience, expertise and knowledge to our organisation.
Chair, Meghan Speers
Meghan is a partner at Deloitte. She is a Chartered Accountant and solicitor and an ovarian cancer survivor, having been diagnosed at 29 years of age. A mother of two, Meghan has been actively involved in raising awareness about ovarian cancer, working closely with Ovarian Cancer Australia, for more than 10 years.
Meghan sees joining the Board of Ovarian Cancer Australia as a chance to give back to an organisation that provided so much support and ensured she didn’t battle ovarian cancer alone. Her ambition is to bring her commercial business expertise with a consumer’s insight and to assist Ovarian Cancer Australia to achieve its bold 2025 vision to reduce the incidence and improve the survival rates of ovarian cancer.
Director: Professor Juliet Bourke
Juliet Bourke is a Non Executive Director and Professor of Practice in the UNSW School of Management and Governance in the Business School. Chair of the AICD 30% Club Education Working Group, and a board member on the Global Institute for Women’s Leadership King’s College London (established and chaired by former Prime Minister Julia Gillard AC), and qChange (a US based tech-start up).
Formerly a partner at Deloitte (2011-2020), and the co-founder of Aequus Partners (2000-2011), Juliet has advised over 200 global organisations on people and culture issues, including American Airlines, APRA, the Australian Army, BHP, Gilead Sciences, Johson & Johnson, Macquarie Group, Qantas, the RBA, Toyota, the United Nations and Woodside. She has served on three Diversity Councils, namely for the RBA, the Australian Navy and Deloitte Australia. Juliet started her career as a lawyer, firstly working in criminal law for the Commonwealth Director of Prosecutions and then in employment law.
Juliet is a TEDx speaker, a 2019 Australian Financial Review Top 100 Women of Influence and is well known for her thought leadership on diversity and inclusion. She has published in the Harvard Business Review, the Australian Financial Review and The Guardian. Her most recent book (published by the Australian Institute of Company Directors) is “Which two heads are better than one? The extraordinary power of diversity of thinking and inclusive leadership” (2021)).
Juliet holds a BA (Psychology Major), LLB, LLM (with Hons) and is a final year PhD candidate (Business School, Brunel University London).
Director: Richard Gosper
Richard Gosper is an Associate Partner at Bain & Company, a global management consulting firm and brings experience in strategy development and digital acumen. His experience working with complex organisations will be beneficial as Ovarian Cancer Australia continues to influence and participate within the broader cancer ecosystem.
Director: Andrew Jolly
Andrew Jolly is a Director at PwC based in Melbourne. He is an experienced technology professional with significant senior digital and program delivery experience across the private and public sectors. Andrew’s experience assisting complex organisations with digital transformation and delivery will be beneficial as Ovarian Cancer Australia continues to navigate the challenging and exciting changing environment.
Director: Melissa McClusky
Melissa McClusky is a partner at KPMG. With over 25 years of management and leadership experience in a career spanning both public and private sector organisations, Mel brings a strong focus on digital programs and excellence in service delivery.